Technology Expertise
- Liver MPS platforms with primary and iPSC-derived cells
- Disease modeling with liver MPS including MASLD/MASH and liver metastatic niche
- Organoid/MPS as drug screening platforms
Disease Focus
- MASLD/MASH
- Various Cancer Types
The Computational, Organoid, and Microphysiological Systems Initiative